Note: This webinar took place on 5 July 2017. You can find a video recording and the presentations used during the webinar below.
A very important result from the EUPATI project was the development, broad consultation and final release of guidances on the best approach to interaction of patients with pharmaceutical industry-led medicines R&D, regulatory authorities, ethics committees and HTA agencies. This webinar focuses on the Guidance on Patient involvement in HTA
- Ingrid Klingmann, EFGCP
- Amy Hunter, Genetic Alliance UK
- Dominique Hamerlijnck, EUPATI Fellow
- Lizzie Thomas, NICE